التفاصيل البيبلوغرافية
| العنوان: |
Classical Presentation of Disseminated Blastomycosis in a 44-Year-Old Healthy Man 3 Months After Diagnosis of COVID-19. |
| المؤلفون: |
Fan, Diana, Ahmad, Ali, Frisby, Jared, Darji, Kavita, Ojeaga, Ashley, Behshad, Ramona, Hurley, M. Yadira, Abate, Mallory, Kunnath, Paul |
| المصدر: |
American Journal of Case Reports; 4/22/2023, Vol. 24, p1-9, 9p |
| مصطلحات موضوعية: |
BLASTOMYCOSIS, COVID-19 testing, MYCOSES, COVID-19 pandemic, COVID-19, AIDS-related opportunistic infections |
| مصطلحات جغرافية: |
MIDWEST (U.S.) |
| الشركة/الكيان: |
CENTERS for Disease Control & Prevention (U.S.) |
| مستخلص: |
Objective: Rare disease Background: During the COVID-19 pandemic, the incidence of opportunistic infections, including fungal infections, has increased. Blastomycosis is caused by inhalation of an environmental fungus, Blastomyces dermatides, which is endemic in parts of the USA and Canada. This case report is of a 44-year-old man from the American Midwest who presented with disseminated blastomycosis infection 3 months following a diagnosis of COVID-19. Case Report: Our patient initially presented to an outpatient clinic with mild upper-respiratory symptoms. He tested positive for SARS-CoV-2 via polymerase chain reaction (PCR). Three months later, he presented to our emergency department due to some unresolved COVID-19 symptoms and the development of a widely disseminated, painful rash of 1-week duration. A positive Blastomyces urine enzyme immunoassay was the first indication of his diagnosis, which was followed by the identification of the pathogen via fungal culture from bronchoscopy samples and pathology from lung and skin biopsies. Given the evidence of dissemination, the patient was treated with an intravenous and oral antifungal regimen. He recovered well after completing treatment. Conclusions: The immunocompetent status of patients should not exclude disseminated fungal infections as a differential diagnosis, despite the less frequent manifestations. This is especially important when there is a history of COVID-19, as this may predispose once-healthy individuals to more serious disease processes. This case supports the recent recommendations made by the U.S. Centers for Disease Control and Prevention (CDC) for increased vigilance regarding fungal infections in patients with a history of COVID-19. [ABSTRACT FROM AUTHOR] |
|
Copyright of American Journal of Case Reports is the property of International Scientific Literature, Inc and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
